Eichenfield Lawrence 4
4 · Forte Biosciences, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2022-02-23+25,000→ 25,000 totalExercise: $1.27Exp: 2032-02-23→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the one (1) year anniversary of the Date of Grant. "Date of Grant" shall mean February 23, 2022.